These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1199734)
1. Identification and quantitation of a 3-benzylidenephthalide contaminant of phenindione tablets and its characterization as a potentially immunogenic substance. Bundgaard H Acta Pharm Suec; 1975; 12(4):333-48. PubMed ID: 1199734 [No Abstract] [Full Text] [Related]
2. Dissolution and disintegration characteristics of some experimental formulations of phenindione tablets. 1. Before storage. Khalil SH; Ali LM; Abdel-Khalek MM Pharmazie; 1973 Oct; 28(10):659-61. PubMed ID: 4783550 [No Abstract] [Full Text] [Related]
3. Dissolution and disintegration characteristics of some experimental formulations of phenindione tablets. 2. After storage at 98 percent relative humidity. Khalil SA; Ali LM; Abdel-Khalek MM Pharmazie; 1973 Oct; 28(10):661-4. PubMed ID: 4783551 [No Abstract] [Full Text] [Related]
4. Characterization of the T-cell response in a patient with phenindione hypersensitivity. Naisbitt DJ; Farrell J; Chamberlain PJ; Hopkins JE; Berry NG; Pirmohamed M; Park BK J Pharmacol Exp Ther; 2005 Jun; 313(3):1058-65. PubMed ID: 15743920 [TBL] [Abstract][Full Text] [Related]
6. Determination of phenindione using organic brominating agents. Abou Ouf A; Walash MI; Rizk M; Belal F Analyst; 1979 Jun; 104(1239):566-8. PubMed ID: 496018 [No Abstract] [Full Text] [Related]
7. The break-up and dissolution of phenindione tablets. Ganderton D; Hadgraft JW; Rispin WT; Thompson AG Pharm Acta Helv; 1967 Mar; 42(3):152-62. PubMed ID: 5584478 [No Abstract] [Full Text] [Related]
8. [About a case of intolerance in a premedication. Demonstration of antipethidine antibodies]. Dixneuf B; Guimbretière J; Dehorne M Anesth Analg (Paris); 1969; 26(3):437-44. PubMed ID: 5804831 [No Abstract] [Full Text] [Related]
12. Sensitivity to phenindione ("Dindevan"). GOULSTON K Med J Aust; 1962 Nov; 2():832-5. PubMed ID: 13949579 [No Abstract] [Full Text] [Related]
13. Identification of an unknown extraneous contaminant in pharmaceutical product analysis. Lin M; Li M; Rustum A J Pharm Biomed Anal; 2007 Dec; 45(5):747-55. PubMed ID: 17928183 [TBL] [Abstract][Full Text] [Related]
14. Fatal nephropathy due to phenindione sensitivity. GALEA EG; YOUNG LN; BELL JR Lancet; 1963 Apr; 1(7287):920-2. PubMed ID: 13946234 [No Abstract] [Full Text] [Related]
15. ORAL ANTICOAGULANT MEDICATION. HUNTER JD N Z Med J; 1964 Apr; 63():245. PubMed ID: 14142122 [No Abstract] [Full Text] [Related]
17. [Apropos of a case of a therapeutic complication due to phenindione]. Paliard P; Moulin G; Motin J; Robillard J; Perrot E Lyon Med; 1967 Sep; 217(37):389-93. PubMed ID: 4247354 [No Abstract] [Full Text] [Related]
18. Analysis of quinocide in unprocessed primaquine diphosphate and primaquine diphosphate tablets using gas chromatography-mass spectrometry with supersonic molecular beams. Brondz I; Fialkov AB; Amirav A J Chromatogr A; 2009 Jan; 1216(5):824-9. PubMed ID: 19108846 [TBL] [Abstract][Full Text] [Related]
19. Polarographic determination of some pharmaceutical products: bromphenindione, trihydroxyethylrutoside, glibenclamide, coenzyme a, doxycycline. Silvestri S Pharm Acta Helv; 1972; 47(3):209-21. PubMed ID: 4624247 [No Abstract] [Full Text] [Related]
20. Phenindione sensitivity and acute renal failure. Nicholls MG; Heale WF N Z Med J; 1970 Apr; 71(455):214-6. PubMed ID: 5270600 [No Abstract] [Full Text] [Related] [Next] [New Search]